These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 26215504)
41. Morphogenetic theory of mental and cognitive disorders: the role of neurotrophic and guidance molecules. Primak A; Bozov K; Rubina K; Dzhauari S; Neyfeld E; Illarionova M; Semina E; Sheleg D; Tkachuk V; Karagyaur M Front Mol Neurosci; 2024; 17():1361764. PubMed ID: 38646100 [TBL] [Abstract][Full Text] [Related]
42. Kidins220 sets the threshold for survival of neural stem cells and progenitors to sustain adult neurogenesis. Del Puerto A; Lopez-Fonseca C; Simón-García A; Martí-Prado B; Barrios-Muñoz AL; Pose-Utrilla J; López-Menéndez C; Alcover-Sanchez B; Cesca F; Schiavo G; Campanero MR; Fariñas I; Iglesias T; Porlan E Cell Death Dis; 2023 Aug; 14(8):500. PubMed ID: 37542079 [TBL] [Abstract][Full Text] [Related]
43. ARMS-NF-κB signaling regulates intracellular ROS to induce autophagy-associated cell death upon oxidative stress. Liao YH; Wu JT; Hsieh IC; Lee HH; Huang PH iScience; 2023 Feb; 26(2):106005. PubMed ID: 36798436 [TBL] [Abstract][Full Text] [Related]
44. Classification for psychiatric disorders including schizophrenia, bipolar disorder, and major depressive disorder using machine learning. Yang Q; Xing Q; Yang Q; Gong Y Comput Struct Biotechnol J; 2022; 20():5054-5064. PubMed ID: 36187923 [TBL] [Abstract][Full Text] [Related]
45. Identification of Peripheral Blood miRNA Biomarkers in First-Episode Drug-Free Schizophrenia Patients Using Bioinformatics Strategy. Jin M; Zhu X; Sun Y; Li Z; Li X; Ai L; He Y; Liu Y; Jia N; Hu G; Cui X; Xie M; Yang Y; Yu Q Mol Neurobiol; 2022 Aug; 59(8):4730-4746. PubMed ID: 35599275 [TBL] [Abstract][Full Text] [Related]
47. Identification of the gene signature reflecting schizophrenia's etiology by constructing artificial intelligence-based method of enhanced reproducibility. Yang QX; Wang YX; Li FC; Zhang S; Luo YC; Li Y; Tang J; Li B; Chen YZ; Xue WW; Zhu F CNS Neurosci Ther; 2019 Sep; 25(9):1054-1063. PubMed ID: 31350824 [TBL] [Abstract][Full Text] [Related]
48. Regulation of BDNF Release by ARMS/Kidins220 through Modulation of Synaptotagmin-IV Levels. López-Benito S; Sánchez-Sánchez J; Brito V; Calvo L; Lisa S; Torres-Valle M; Palko ME; Vicente-García C; Fernández-Fernández S; Bolaños JP; Ginés S; Tessarollo L; Arévalo JC J Neurosci; 2018 Jun; 38(23):5415-5428. PubMed ID: 29769266 [TBL] [Abstract][Full Text] [Related]
49. Analysis of 182 cerebral palsy transcriptomes points to dysregulation of trophic signalling pathways and overlap with autism. van Eyk CL; Corbett MA; Gardner A; van Bon BW; Broadbent JL; Harper K; MacLennan AH; Gecz J Transl Psychiatry; 2018 Apr; 8(1):88. PubMed ID: 29681622 [TBL] [Abstract][Full Text] [Related]
50. Neurotrophin signalling: novel insights into mechanisms and pathophysiology. Mitre M; Mariga A; Chao MV Clin Sci (Lond); 2017 Jan; 131(1):13-23. PubMed ID: 27908981 [TBL] [Abstract][Full Text] [Related]
51. Parsing psychosis subtypes through investigations of rare genetic variants. Bergen SE EBioMedicine; 2016 Apr; 6():16-17. PubMed ID: 27211538 [No Abstract] [Full Text] [Related]
52. Stepping Out of the Shade: Control of Neuronal Activity by the Scaffold Protein Kidins220/ARMS. Scholz-Starke J; Cesca F Front Cell Neurosci; 2016; 10():68. PubMed ID: 27013979 [TBL] [Abstract][Full Text] [Related]
53. Prefrontal neuronal integrity predicts symptoms and cognition in schizophrenia and is sensitive to genetic heterogeneity. Malaspina D; Kranz TM; Heguy A; Harroch S; Mazgaj R; Rothman K; Berns A; Hasan S; Antonius D; Goetz R; Lazar M; Chao MV; Gonen O Schizophr Res; 2016 Apr; 172(1-3):94-100. PubMed ID: 26925801 [TBL] [Abstract][Full Text] [Related]
54. Early Life Stress Effects on Glucocorticoid-BDNF Interplay in the Hippocampus. Daskalakis NP; De Kloet ER; Yehuda R; Malaspina D; Kranz TM Front Mol Neurosci; 2015; 8():68. PubMed ID: 26635521 [TBL] [Abstract][Full Text] [Related]
55. Rare variants in the neurotrophin signaling pathway implicated in schizophrenia risk. Kranz TM; Goetz RR; Walsh-Messinger J; Goetz D; Antonius D; Dolgalev I; Heguy A; Seandel M; Malaspina D; Chao MV Schizophr Res; 2015 Oct; 168(1-2):421-8. PubMed ID: 26215504 [TBL] [Abstract][Full Text] [Related]
56. Phenotypically distinct subtypes of psychosis accompany novel or rare variants in four different signaling genes. Kranz TM; Berns A; Shields J; Rothman K; Walsh-Messinger J; Goetz RR; Chao MV; Malaspina D EBioMedicine; 2016 Apr; 6():206-214. PubMed ID: 27211562 [TBL] [Abstract][Full Text] [Related]
57. Association of neurotrophin-3 gene variant with severe forms of schizophrenia. Hattori M; Nanko S Biochem Biophys Res Commun; 1995 Apr; 209(2):513-8. PubMed ID: 7733919 [TBL] [Abstract][Full Text] [Related]
58. State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations. Lang UE; Jockers-Scherübl MC; Hellweg R J Neural Transm (Vienna); 2004 Mar; 111(3):387-411. PubMed ID: 14991461 [TBL] [Abstract][Full Text] [Related]
59. De novo mutations from sporadic schizophrenia cases highlight important signaling genes in an independent sample. Kranz TM; Harroch S; Manor O; Lichtenberg P; Friedlander Y; Seandel M; Harkavy-Friedman J; Walsh-Messinger J; Dolgalev I; Heguy A; Chao MV; Malaspina D Schizophr Res; 2015 Aug; 166(1-3):119-24. PubMed ID: 26091878 [TBL] [Abstract][Full Text] [Related]